• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

HRS 2012

HRS 2012 Roundup: Cameron Health, Topera Medical and Riata take center stage

May 14, 2012 By MassDevice staff Leave a Comment

MassDevice.com news

More than 35,000 physicians, allied healthcare providers and industry representatives descended on the cavernous convention center in Boston’s up-and-coming Seaport section for the Heart Rhythm Society’s annual meeting.

Filed Under: Cardiac Implants, News Well Tagged With: Biosense Webster, Biotronik, Boston Scientific, Cameron Health Inc., Cardiac Rhythm Management, GE Healthcare, HRS 2012, Rhythmia Medical Inc., stjudemedical, Topera Medical

MassDevice.com +7 | The top 7 med-tech stories for the week of May 7, 2012.

May 12, 2012 By MassDevice staff Leave a Comment

Plus Seven

Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.

If you read nothing else this weekend, make sure you’re still in the know with MassDevice +7.

Filed Under: News Well, Recalls, Wall Street Beat Tagged With: Boston Scientific, Cameron Health Inc., Cardiac Rhythm Management, Covidien, depuysynthes, Hips, HRS 2012, Johnson and Johnson, Plus 7, Premier Inc., Renal, stjudemedical, U.S. House of Representatives

HRS 2012: Cost-effective treatment with CRT-Ds means giving them to more people

May 11, 2012 By MassDevice staff Leave a Comment

Medtronic logo

Putting CRT defibrillators in more patients is a cost-effective way to treat mild heart failure, according to a Medtronic (NYSE:MDT) study unveiled at today’s Heart Rhythm Society meeting in Boston.

Filed Under: News Well Tagged With: Cardiac Rhythm Management, HRS 2012

HRS 2012: Is Cameron Health’s ‘leadless’ ICD a niche product or a game-changer?

May 11, 2012 By Brad Perriello Leave a Comment

Cameron Health S-ICD

The so-called "leadless" implantable cardiac defibrillator made by Cameron Health made its debut at the Heart Rhythm Society’s annual meeting this week, generating considerable excitement among physicians here in Boston.

Two studies presented at the conference, 1 sponsored by Cameron Health to back its investigational device exemption application with the FDA and a 2nd, "real-world" evaluation of European patients, both showed that the subcutaneous ICD has comparable safety and effectiveness rates as more traditional transvenous ICDs.

Filed Under: News Well Tagged With: Boston Scientific, Cameron Health Inc., Cardiac Rhythm Management, HRS 2012

HRS 2012: Boston Scientific’s Watchman as effective as Warfarin

May 11, 2012 By Brad Perriello Leave a Comment

HRS 2012

A medical device made by Boston Scientific (NYSE:BSX) designed to trap blood clots in the heart could be an important tool for preventing stroke in high-risk atrial fibrillation patients, researchers said today at the annual Heart Rhythm Society meeting in Boston.

Filed Under: Cardiac Implants, News Well Tagged With: Boston Scientific, Clinical Trials, HRS 2012

HRS 2012 Update: Ablation beats drugs in safety, efficacy in AF patients

May 11, 2012 By MassDevice staff Leave a Comment

Heart Rhythm Society 2012 meeting

Patients with a common heart rhythm disorder who received treatment with cardiac ablation were arrhythmia-free longer than patients taking drugs, suggesting that ablation should be a 1st-order approach to managing an erratic heart beat, according to a new study.

Unveiled at this year’s Heart Rhythm Society in Boston, the study found that patients with paroxysmal atrial fibrillation who received ablation therapy were 20% less likely to see a recurrence than patients taking anti-arrhythmic medication.

Filed Under: News Well, Recalls Tagged With: Ablation, Cardiac Rhythm Management, Endosense SA, HRS 2012, stjudemedical, Topera Medical

GE Healthcare inks co-development deal with J&J’s Biosense Webster

May 11, 2012 By MassDevice staff Leave a Comment

MassDevice.com news
MassDevice.com news

Filed Under: News Well Tagged With: Ablation, Biosense Webster, Cardiac Rhythm Management, GE Healthcare, HRS 2012, Johnson and Johnson

Biotronik touts FDA approval for next-gen heart devices at HRS 2012 | Regulatory Roundup

May 11, 2012 By MassDevice staff Leave a Comment

MassDevice.com Regulatory Roundup

 Biotronik wins FDA aproval for next-gen heart failure devices

Filed Under: 510(k), News Well, Pre-Market Approval (PMA) Tagged With: Biotronik, Cardiac Rhythm Management, HRS 2012

HRS 2012: New imaging may better predict who needs an ICD | MassDevice.com On Call

May 11, 2012 By MassDevice staff Leave a Comment

MassDevice On Call

MASSDEVICE ON CALL — A new imaging tool could help cardiologists better determine which patients are at the highest risk of sudden cardiac arrest and would most likely benefit from receiving an implanted cardioverter defibrillator, according to researchers at the University of Buffalo.

The researchers reported the findings of the UB Parapet study, touted as the largest PET study imaging study ever done on cardiac arrest, at this year’s Heart Rhythm Society meeting.

Filed Under: Food & Drug Administration (FDA), News Well Tagged With: Abbott, American Heart Assn., Cardiac Rhythm Management, Corindus Vascular Robotics, Heart Rhythm Society, HRS 2012, On Call, Yale University

HRS 2012: Boston Scientific’s Watchman as effective as Warfarin

May 11, 2012 By Brad Perriello Leave a Comment

HRS 2012

A medical device made by Boston Scientific (NYSE:BSX) designed to trap blood clots in the heart could be an important tool for preventing stroke in high-risk atrial fibrillation patients, researchers said today at the annual Heart Rhythm Society meeting in Boston.

Filed Under: Cardiac Implants Tagged With: Boston Scientific, Clinical Trials, HRS 2012

HRS 2012: St. Jude calms fears about Durata lead, touts 10-year ICD study

May 10, 2012 By MassDevice staff Leave a Comment

Heart Rhythm Society 2012 meeting

St. Jude Medical (NYSE:STJ) tried to distance its Durata defibrillator leads from their troubled Riata predecessor and unveiled the results of the decade-long SCD-HeFT heart failure study during separate presentations at this year’s Heart Rhythm Society meeting in Boston, Mass.

Filed Under: News Well, Recalls, Research & Development Tagged With: Cardiac Rhythm Management, Clinical Trials, Heart Rhythm Society, HRS 2012, stjudemedical

  • Page 1
  • Page 2
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy